Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector specializing in pain management pharmaceuticals, is capturing investor attention with its remarkable potential upside...
CorMedix Inc. (NASDAQ: CRMD) stands out in the biotechnology sector with a remarkable potential upside of 97.34%, according to analyst ratings. This intriguing figure is further..
Altimmune, Inc. (NASDAQ: ALT) is making significant waves in the biotechnology sector with its groundbreaking work in developing therapies for serious liver diseases. This Gaithersburg, Maryland-based..
RxSight, Inc. (NASDAQ: RXST), a healthcare company specializing in medical devices, particularly those used in cataract surgery, is capturing investor attention with its innovative approach in..
Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the healthcare sector, is garnering attention from investors due to its innovative solutions in the diagnostics and..
Arbutus Biopharma Corporation (NASDAQ: ABUS) stands out in the biotechnology sector with its focus on developing novel therapeutics for infectious diseases, notably chronic Hepatitis B virus..
AxoGen, Inc. (NASDAQ: AXGN) has emerged as a compelling player in the healthcare sector, particularly in the medical devices industry. Specializing in peripheral nerve regeneration and..
Investors seeking opportunities in the healthcare sector may find Delcath Systems, Inc. (NASDAQ: DCTH) a compelling prospect. The company, which specializes in interventional oncology, primarily focuses..
REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company based in Rockville, Maryland, is garnering significant attention from investors due to its promising advancements in gene therapy..
In the competitive landscape of biotechnology, Spyre Therapeutics, Inc. (NASDAQ: SYRE) stands out not just for its cutting-edge research in inflammatory bowel and rheumatic diseases but..
Dianthus Therapeutics, Inc. (DNTH) is making waves in the biotechnology industry with its promising pipeline of therapies aimed at severe autoimmune diseases. As a clinical-stage biotechnology..
InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector with a focus on medical devices, offers a compelling opportunity for investors seeking exposure to..
Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, has captured investor attention with a substantial upside potential of 93.82%. This clinical-stage biopharmaceutical..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) stands out in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a current market cap..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector, a space known for its volatility but also its potential for groundbreaking advancements. With..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent player in the biotechnology industry, is capturing investor attention with its strategic focus on enabling the development of..
CareDx, Inc. (NASDAQ: CDNA) stands at the forefront of the healthcare sector, specializing in diagnostics and research with a focus on improving outcomes for transplant patients...
Neuropace, Inc. (NASDAQ: NPCE) stands at a pivotal point in the healthcare sector with its innovative approach to treating drug-resistant focal epilepsy. As a key player..
Investors keeping a close watch on uniQure N.V. (NASDAQ: QURE) are presented with an intriguing investment opportunity in the biotechnology sector, particularly given the company’s focus..
